Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04727489

Study of the Genetic Factors Involved in Autism and Related Disorders

Status
Recruiting
Phase
Study type
Observational
Enrollment
3,800 (estimated)
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France · Other Government
Sex
All
Age
24 Months – 70 Years
Healthy volunteers
Accepted

Summary

The main objective of the study is to define, for Autism Spectrum Disorder, the extent of genetic variation in synaptic pathways that may be targeted for therapeutic development. For this purpose the investigators will take advantage of large, well-characterized cohorts of patients with Autism Spectrum Disorder for genetic screenings. Targeted sequencing of selected synaptic genes, previously associated with Autism Spectrum Disorder, will be carried out in these cohorts with deep coverage of coding regions and a strong focus on previously untested regulatory regions. Genomic data from Copy Number Variant, whole genome sequencing and exome sequencing, available for some of these patients, will be integrated in the overall analysis. The investigators will strongly emphasize the establishment of comprehensive genotype/phenotype correlations.

Detailed description

Aim 1: To identify genetic variants in selected synaptic genes, by targeted sequencing with deep coverage of coding regions and a strong focus on previously untested regulatory regions in Autism Spectrum Disorder Aim 2: To define the range of clinical phenotypes caused by mutations in synaptic genes by establishing detailed genotype/phenotype correlations and analyzing segregation in families with multiple individuals affected by Autism Spectrum Disorder, Autism Spectrum Disorder traits or other neuropsychiatric disorders Aim 3: To identify the neuronal phenotypes caused by deleterious synaptic mutations for further translational studies

Conditions

Interventions

TypeNameDescription
GENETICDNA from subjects will be stored in the biobank of our study.Diagnostic Interview-Revised (ADI-R) criteria for autism and Autism Diagnostic Observation Schedule (ADOS-G) criteria for autism or Autism Spectrum Disorders.

Timeline

Start date
2021-03-30
Primary completion
2036-03-01
Completion
2036-03-01
First posted
2021-01-27
Last updated
2025-12-23

Locations

6 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04727489. Inclusion in this directory is not an endorsement.